Home/Companies/Healthcare/Diaverum

Diaverum

Healthcare·

Sweden·Exited 2023·Held 16yr

Entry

2007

Hold

16yr

Exit

2023

Who owns Diaverum?

Diaverum is a Swedish Healthcare company, now owned by M42, which acquired it in 2023 from Bridgepoint.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY

Most recent investor

Bridgepoint

Europe IV (BE IV) · 2008 · Buyout

2 ownership periods · full history below

Key facts

HQSweden

SectorHealthcare

Ownership history

1 ownership period · 1 lender on file

Exited

Last exited in 2023 to M42 (Mubadala / G42 healthcare JV).

1 holder · 1 lender · 2007 · present

BridgepointExited 2023

2007 · 2023(16yr) · Europe IV (BE IV) · 2008 · Buyout

Trade Sale · to M42 (Mubadala / G42 healthcare JV)

Bridgepoint sold Diaverum to M42 in 2023 after 16 years.

CIC Private DebtLender

2021 · present(5yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt

More from Europe IV (BE IV)

Other portfolio companies in the same fund.

to Golden Gate Capital

to Artemis (Pinault family)

to Partners Group (consortium w/ CDPQ, CIC)

Infront Sports & Media

2.5xExited 2015

Business Services

Switzerland· 2011

to Dalian Wanda Group

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Questions

Who owns Diaverum?

Diaverum is now owned by M42, which acquired it in 2023 from Bridgepoint.

When did M42 acquire Diaverum?

M42 acquired Diaverum in 2023, buying from Bridgepoint.

Who did Diaverum sell to?

Bridgepoint sold Diaverum to M42 in 2023 (Trade Sale).

Who has owned Diaverum over time?

Diaverum has been through 2 private-equity ownership periods: Bridgepoint · via Europe IV (BE IV) · 2007–2023 · sold to M42 · (Trade Sale); CIC Private Debt · via CM-CIC Debt Fund 3 · 2021–2023.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue